Diabetes Management Device System Market Size, Share, Growth Forecast 2020- 2026
The report analyzes and forecasts the Diabetes Management Device System Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Diabetes Management Device System Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Diabetes Management Device System Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Diabetes Management Device System Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/1683
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The players profiled in the report include Abbott, Bayer AG, Becton, Dickinson and Company, Hoffman-La Roche Ltd., Braun Melsungen AG, PHC Holdings Corporation, Medtronic, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., and DexCom, Inc.
The major market segments of Diabetes Management Device System Market are as below:
By Product
Monitoring Devices
- Blood Glucose Meters
- Continuous Glucose Monitoring Devices
- Self-monitoring Blood Glucose Systems
- Test Strips
- Lancets
- others
Treatment Devices
- Insulin Pen
- Insulin Pumps
- Insulin Jet Injectors
- Insulin Syringes
- Others
By Distribution Channel
- Institutional Sales
- Retail Sales
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Diabetes Management Device System
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Diabetes Management Device System Market By Product
1.2.2.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Diabetes Management Device System Market Revenue Share By Product in 2018
1.2.2.3. Monitoring Devices
1.2.2.3.1. Blood Glucose Meters
1.2.2.3.2. Continuous Glucose Monitoring Devices
1.2.2.3.3. Self-monitoring Blood Glucose Systems
1.2.2.3.4. Test Strips
1.2.2.3.5. Lancets
1.2.2.3.6. others
1.2.2.4. Treatment Devices
1.2.2.4.1. Insulin Pen
1.2.2.4.2. Insulin Pumps
1.2.2.4.3. Insulin Jet Injectors
1.2.2.4.4. Insulin Syringes
1.2.2.4.5. Others
1.2.3. Diabetes Management Device System Market By Distribution Channel
1.2.3.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.2. Global Diabetes Management Device System Market Revenue Share By Distribution Channel in 2018
1.2.3.3. Institutional Sales
1.2.3.4. Retail Sales
1.2.4. Diabetes Management Device System Market By Geography
1.2.4.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Diabetes Management Device System Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Diabetes Management Device System Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Diabetes Management Device System Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Diabetes Management Device System Major Manufacturers in 2018
CHAPTER 4. DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY PRODUCT
4.1. Global Diabetes Management Device System Revenue By Product
4.2. Monitoring Devices
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.2.3. Blood Glucose Meters
4.2.4. Continuous Glucose Monitoring Devices
4.2.5. Self-monitoring Blood Glucose Systems
4.2.6. Test Strips
4.2.7. Lancets
4.2.8. others
4.3. Treatment Devices
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3.3. Insulin Pen
4.3.4. Insulin Pumps
4.3.5. Insulin Jet Injectors
4.3.6. Insulin Syringes
4.3.7. Others
CHAPTER 5. DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY DISTRIBUTION CHANNEL
5.1. Global Diabetes Management Device System Revenue By Distribution Channel
5.2. Institutional Sales
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Retail Sales
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. NORTH AMERICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
6.1. North America Diabetes Management Device System Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Diabetes Management Device System Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 7. EUROPE DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
7.1. Europe Diabetes Management Device System Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
8.1. Asia-Pacific Diabetes Management Device System Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 9. LATIN AMERICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
9.1. Latin America Diabetes Management Device System Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
10.1. Middle East & Africa Diabetes Management Device System Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East & Africa Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Abbott
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Bayer AG
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Becton
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Dickinson and Company
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Hoffman-La Roche Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Braun Melsungen AG
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. PHC Holdings Corporation
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Medtronic
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Novo Nordisk A/S
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Sanofi
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Tandem Diabetes Care, Inc.
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. DexCom, Inc.
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Others
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/1683
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
